IN 1941 Levine et al. 1 proposed an etiology for erythroblastosis fetalis that required the entrance of fetal red blood cells into the maternal circulation. This requirement then led to the ...

In turn, these red blood cells assume a characteristic ... One approach to a cure is engineering a patient’s stem cells to reactivate fetal haemoglobin. While present at high levels in infants ...

during which maternal antibodies can attack fetal red blood cells (RBCs), inducing hemolytic disease in the fetus. In future pregnancies, the mother's antibodies can attack the RBCs of the unborn ...

On the basis of her anti-D antibody titers, she was presumed to be RhD alloimmunized from exposure to RhD-positive fetal red blood cells (RBCs) and not from the administration of Rh o D immune ...

Right now, approximately 20 billion red blood cells are busy traveling through your blood vessels. They are delivering oxygen ...

It's a bit simplistic, but you can think of the Rh factor as a protein that is either present (positive) or absent (negative) on red blood ... neutralizes any fetal blood cells in their ...

The team quantified the gene expression of more than 58,000 individual hematopoietic (blood) stem cells at seven stages, from early fetal development ... the production of red blood cells for ...

An SCD patient in Bahrain received the gene-editing therapy Casgevy, marking the first time the treatment has been given outside the U.S.

Vertex has entered a reimbursement agreement with NHS England enabling eligible SCD patients to access Casgevy in the public health system.